Posted in

SINGLE-GENE DISORDERS WITH ATYPICAL PATTERNS OF INHERITANCE – Self Learning series # 11, Page # 105, Ch# 4

SINGLE-GENE DISORDERS WITH ATYPICAL PATTERNS OF INHERITANCE - Self Learning series # 11, Page # 105, Ch# 4
  • Some single-gene disorders do not follow classic Mendelian inheritance.
  • Three important groups:
    • triplet repeat mutations
    • mitochondrial gene mutations
    • abnormalities involving genomic imprinting

Triplet Repeat Mutations

  • These disorders result from abnormal expansion of a 3-nucleotide sequence within a gene.
  • Increasing repeats → gene dysfunction.
  • Examples include:
    • Fragile X syndrome
    • Huntington disease
    • myotonic dystrophy
    • spinocerebellar ataxias
  • About 50 diseases are known to result from these mutations, and those identified so far are associated with neurodegenerative abnormalities.

Fragile X Syndrome (FXS)

  • Fragile X syndrome is the prototype triplet-repeat disorder.
  • It results from expansion of CGG repeats in the FMR1 gene.
  • FXS is:
    • the most common genetic cause of intellectual disability in males
    • overall second only to Down syndrome
  • Frequency:
    • males → about 1 in 1550
    • females → about 1 in 8000
  • FMR1 repeat expansions are also associated with:
    • fragile X–associated tremor/ataxia syndrome
    • fragile X–associated primary ovarian insufficiency
  • The name “fragile X” came from the old cytogenetic appearance:
    • cells grown in folate-deficient medium showed a constriction/discontinuity in the long arm of X
    • this method has largely been replaced by DNA analysis of repeat number
  • Typical affected males may show:
    • severe intellectual disability
    • long face
    • large mandible
    • large, everted ears
    • macroorchidism
  • Other possible features:
    • hyperextensible joints
    • high-arched palate
    • mitral valve prolapse
  • These physical findings may be subtle or absent.
  • The most consistent distinctive physical finding after puberty is macroorchidism, present in at least 90% of affected males.
  • Neurologic and behavioral manifestations include:
    • epilepsy → about 30%
    • aggressive behavior → about 90%
    • autism spectrum disorder
    • anxiety/hyperactivity disorders
  • FXS mainly affects males, but its inheritance differs from typical X-linked recessive disorders (Fig. 4.21).
  • Carrier males:
    • about 20%–50% of males carrying an FMR1 expansion may lack typical neurologic disease
    • they transmit the altered gene to all daughters
    • affected descendants may appear in later generations
    • these men are called normal transmitting males
  • Affected females:
    • about 20% of carrier females may show intellectual disability and other manifestations
    • this is more frequent than in typical X-linked recessive diseases
  • Anticipation:
    • disease becomes more severe in successive generations
    • caused by progressive expansion of the triplet repeat
  • The unusual inheritance is explained by the dynamic nature of CGG repeat expansion.
  • Repeat numbers:
    • normal → average around 29 CGG repeats
    • premutation → 52–200 repeats
    • full mutation → 200–4000 repeats
  • Carrier males and females generally carry a premutation.
  • During oogenesis, a premutation may expand further: premutation → more CGG repeats → full mutation
  • This expansion does not usually occur during spermatogenesis.
  • A carrier female can therefore transmit a full mutation to either:
    • sons
    • daughters
  • This explains:
    • why some carrier males remain unaffected → premutation
    • why some carrier females can have affected children → premutation expands during oogenesis

KEY CONCEPT

  • Fragile X = FMR1 CGG triplet-repeat expansion.
  • Normal ≈ 29 repeats → premutation 52–200 → full mutation 200–4000.
  • Expansion mainly occurs during oogenesis.
  • More repeats across generations → anticipation → more severe disease.
  • Major clues:
    intellectual disability + long face + large ears + macroorchidism.

CONCEPTUAL EXAMPLES

  • Male carries a premutation → may appear normal → passes it to all daughters → normal transmitting male.
  • Daughter inherits premutation → during her oogenesis repeats expand → child receives full mutation → Fragile X syndrome.
  • Repeat size increases from one generation to the next → disease becomes more severe → anticipation.

FIG. 4.21 — FRAGILE X PEDIGREE

🧠 Simplest idea

Fragile X shows anticipation: a small FMR1 CGG-repeat expansion (premutation) can become a full mutation when transmitted through a carrier mother → the next generation may develop Fragile X syndrome.

Whole figure in one flow

Carrier male (premutation)
→ gives his abnormal X to ALL daughters
→ daughters become carrier females
→ during formation of their eggs, the repeat may expand
full mutation
→ affected sons and variably affected daughters.

🎨 COLOR / SYMBOL GUIDE

  • 🔵 Square = male
  • 🩷 Circle = female
  • 🔵 Long chromosome = X chromosome
  • 🟢 Small chromosome = Y chromosome
  • 🔴 Segment on X = FMR1 repeat expansion
  • ⚫ Family lines = inheritance pathway

1️⃣ TOP — CARRIER MALE + NORMAL FEMALE

👨 Carrier male

He has:

X with premutation + normal Y

The 🔴 marked area on his X represents the expanded FMR1 CGG repeat.

A premutation usually means approximately:

55–200 CGG repeats

It is not yet the classic full Fragile X mutation.

Why can a premutation male look normal?

Because FMR1 is generally still expressed.

So he usually does not have classic Fragile X syndrome.

However, some older male premutation carriers can develop:

FXTAS

= Fragile X–associated tremor/ataxia syndrome.

2️⃣ Why are his SONS normal?

A father gives:

Y chromosome → sons

He does not give his X chromosome to sons.

Therefore:

Carrier father → son gets Y → no paternal FMR1 premutation

✅ Sons shown here are normal.

3️⃣ Why are ALL his DAUGHTERS carriers?

A father gives:

his only X chromosome → every daughter

Since his X carries the premutation:

Carrier father
→ premutation X
all daughters receive it

Their mother supplies a normal X.

So daughters become:

Premutation X / normal X

= carrier females

🧠 Key rule:

Father gives X to ALL daughters, Y to ALL sons.

4️⃣ MIDDLE — CARRIER FEMALE

A carrier female has:

one normal X + one premutation X

She may appear normal.

But some premutation females can develop:

Fragile X–associated primary ovarian insufficiency

→ reduced ovarian function / premature ovarian failure.

5️⃣ ⭐ MOST IMPORTANT ARROW — Premutation → Full mutation

During:

OOGENESIS

= formation of eggs in the carrier female

the CGG repeats may become longer.

So:

Premutation
⬇️ repeat expansion

FULL MUTATION

A full mutation generally means:

>200 CGG repeats

This is the key reason disease becomes more severe in later generations.

🧠 This is called:

ANTICIPATION

More repeats in later generation → greater likelihood/severity of disease.6️⃣ BOTTOM LEFT — MALE WITH FULL MUTATION

A son receives:

  • Y from father
  • abnormal X from carrier mother

If that maternal X has expanded to a full mutation:

Xfull mutation + Y

⬇️

Affected male

Why severe?

A male has only one X chromosome.

There is no second normal FMR1 copy to compensate.

7️⃣ What happens molecularly?

Full mutation:

>200 CGG repeats
→ methylation of the FMR1 promoter
FMR1 gene silenced
→ ↓ FMRP
→ abnormal synaptic development/function
→ Fragile X phenotype.

Simple:

Too many CGGs → gene switched OFF → FMRP ↓ → neurologic problems BOTTOM MIDDLE — Female with full mutation

A daughter may receive:

one normal X + one full-mutation X

But females have two X chromosomes.

Because of random:

X-inactivation

some cells use the normal X and some use the abnormal X.

Therefore females are:

variably affected

The figure emphasizes that only about 50% may show clinical manifestations, often milder than affected males.

9️⃣ Why are some children completely normal?

A carrier mother does not pass the abnormal X to every child.

Each child has a chance of receiving:

  • normal maternal X
    or
  • abnormal maternal X.

Thus some sons and daughters remain normal.

⭐ MOST IMPORTANT INHERITANCE CONCEPT

👨 Carrier father

Premutation X

ALL daughters = premutation carriers
NO sons inherit his abnormal X

👩 Carrier mother

Premutation may expand during oogenesis

→ full mutation can appear in children
males with full mutation = affected
females with full mutation = variably affected

🧠 Why does Fragile X show “anticipation”?

Because:

CGG repeats expand between generations

especially during maternal transmission.

So:

Premutation
→ larger repeat
→ full mutation
→ disease appears/becomes more severe.

🔥 Fastest exam recall

FMR1 gene → X chromosome

Premutation = ~55–200 CGG repeats
Full mutation = >200 repeats

Full mutation → hypermethylation → FMR1 OFF → ↓FMRP

Inheritance:

Carrier father → all daughters carriers, no affected sons from him

Carrier mother → repeat can expand → affected sons + variably affected daughters

⭐ One-line memory

Fragile X = maternal CGG-repeat expansion → FMR1 silencing → anticipation; males are usually more severely affected.

FIG. 4.22 — FMRP FUNCTION IN NEURONS

🧠 Simplest idea

FMRP binds selected mRNAs, carries them to dendrites/axons, and controls when ribosomes translate them into proteins. These local proteins are important for synaptic plasticity, learning, and memory.

Whole figure in one flow

FMRP + mRNA → transport through neuron → reaches dendrite/axon → ribosome → controlled local protein synthesis → normal synaptic function

1️⃣ Yellow cell = Neuron

The large yellow structure is the nerve cell.

  • Upper branches = dendrites
  • Long lower process = axon
  • Purple central area = nucleus

2️⃣ 🔴 FMRP

The red structure = FMRP
FMRP = Fragile X messenger ribonucleoprotein

It is an RNA-binding protein.

Main job:

FMRP binds particular mRNAs and regulates their translation.

🧠 Think:

FMRP = mRNA transporter + translation controller

3️⃣ 🟢🔴 FMRP–mRNA complex

Green + red structure = FMRP bound to mRNA.

Black arrows show:

FMRP binds mRNA
→ forms FMRP–mRNA complex
→ complex moves away from the cell body.

4️⃣ Black arrows = Transport

The complex travels toward:

➡️ Dendrites

and

⬇️ Axon

This allows the neuron to carry the instructions for making proteins close to where those proteins are actually needed.

Easy concept:

Instead of making every protein in the cell body:

Neuron sends mRNA to the destination → makes protein locally.

5️⃣ 🔵 Ribosomes

Blue circles = ribosomes.

When the FMRP–mRNA complex reaches the correct location:

Ribosome reads mRNA
translation
→ new protein produced.

6️⃣ RIGHT — Dendritic proteins

At the dendrite:

FMRP-controlled mRNA
→ ribosome
→ 🟠 wavy dendritic proteins

These proteins help modify the synapse.

⬇️

Synaptic plasticity

= ability of synapses to become stronger or weaker with activity.

This is essential for:

Learning + memory

7️⃣ BOTTOM — Axonal proteins

The same idea occurs in the axon:

mRNA transported into axon
→ local ribosomes translate it
axonal proteins

These proteins help maintain and modify axonal function.

⭐ Why is FMRP important in Fragile X syndrome?

Normally:

FMRP → keeps local mRNA translation under proper control

In Fragile X syndrome:

FMR1 gene silenced
↓ FMRP
→ excessive/uncontrolled translation of certain synaptic mRNAs
→ abnormal synaptic proteins
→ impaired synaptic plasticity
→ problems with learning and cognition.

🎨 COLOR / ARROW GUIDE

  • 🟡 Yellow = neuron
  • 🟣 Purple center = nucleus
  • 🔴 Red = FMRP
  • 🟢 structure around FMRP = bound mRNA complex
  • 🔵 Blue circles = ribosomes
  • 🟠 Wavy lines = newly made proteins
  • ⚫ Black arrows = movement of FMRP–mRNA complexes

🧠 Fastest exam recall

FMRP binds mRNA → transports it to dendrites/axons → controls local translation → normal synaptic plasticity.

🔥 Fragile X:

↓ FMRP → ↑ inappropriate synaptic protein translation → abnormal synaptic function → impaired learning/memory.

Fragile X–Associated Tremor/Ataxia Syndrome and Fragile X–Associated Primary Ovarian Failure

  • FMR1 CGG premutations can cause disorders different from classic fragile X syndrome.
  • These disorders result from a toxic gain of function, rather than loss of FMRP.
  • Two important disorders are:
    • Fragile X–associated primary ovarian failure
    • Fragile X–associated tremor/ataxia syndrome
  • Fragile X–associated primary ovarian failure:
    • occurs in about 20% of females carrying an FMR1 premutation
    • ovarian failure develops before age 40
    • causes:
      • menstrual irregularities
      • decreased fertility
  • Fragile X–associated tremor/ataxia syndrome:
    • occurs in about 50% of premutation-carrying males
    • usually begins in the sixth decade of life
    • is a progressive neurodegenerative disorder
    • major manifestations:
      • intention tremor
      • cerebellar ataxia
    • may later progress to parkinsonism

KEY CONCEPT

  • FMR1 full mutation → fragile X syndrome → loss of FMRP function.
  • FMR1 premutation → toxic gain of function → ovarian failure in females or tremor/ataxia syndrome in older males.
  • Female premutation carrier → premature ovarian failure + reduced fertility.
  • Male premutation carrier → late-onset tremor + ataxia ± parkinsonism.

CONCEPTUAL EXAMPLES

  • Woman carrying an FMR1 premutation develops irregular periods before age 40 → fragile X–associated primary ovarian failure.
  • Older man carrying an FMR1 premutation develops intention tremor followed by gait incoordination → fragile X–associated tremor/ataxia syndrome.

Pathogenesis

  • In some FMR1 premutation carriers, the gene is not methylated or silenced.
  • Instead: FMR1 remains active → excess CGG-containing FMR1 mRNA is produced
  • This abnormal mRNA becomes toxic.
  • Toxic FMR1 mRNA:
    • binds RNA-binding proteins
    • traps/sequesters them
    • prevents them from performing their normal functions
  • In affected males: expanded FMR1 mRNA + trapped RNA-binding proteins → nuclear aggregates → intranuclear inclusions
  • These inclusions occur in both:
    • central nervous system
    • peripheral nervous system
  • This toxic RNA mechanism contributes to fragile X–associated tremor/ataxia syndrome.
  • The mechanism of fragile X–associated primary ovarian insufficiency is less clear.
  • FMR1 mRNA aggregates have been found in:
    • granulosa cells
    • ovarian stromal cells
  • These aggregates may cause: ovarian follicle injury/death → premature ovarian failure
  • General principles of trinucleotide repeat diseases:
    • Repeat expansion alters gene function.
    • The number of repeats needed to change a premutation → full mutation differs between diseases.
  • Site of repeat expansion also differs:
    • Fragile X syndrome → expansion mainly during oogenesis
    • Huntington disease → expansion may occur during spermatogenesis
  • Repeat expansions may occur in:
    • untranslated/noncoding regions
    • coding regions (Fig. 4.23)
  • Expansion in a noncoding region usually causes: gene silencing → ↓ protein production → loss of function Example: Fragile X → ↓ FMRP
  • Expansion in a coding region usually produces: abnormal protein → misfolding → toxic gain of function Example: Huntington disease
  • Many toxic coding-region mutations involve CAG repeats.
  • CAG codes for glutamine → expanded CAG repeats produce long polyglutamine tracts.
  • These disorders are therefore called polyglutamine diseases.
  • Misfolded proteins commonly accumulate as cytoplasmic aggregates, especially in nervous tissue.

KEY CONCEPT

  • FMR1 premutation → gene remains active → toxic CGG-containing mRNA → traps RNA-binding proteins → cell dysfunction.
  • Fragile X full mutation → methylation + gene silencing → loss of FMRP.
  • Noncoding repeat expansion → usually loss of function.
  • Coding CAG expansion → polyglutamine misfolded protein → toxic gain of function.

CONCEPTUAL EXAMPLES

  • Premutation FMR1 mRNA traps important proteins in neurons → nuclear inclusions → tremor/ataxia.
  • FMR1 RNA aggregates in ovarian cells → possible follicle loss → premature ovarian insufficiency.
  • CAG expansion in a coding region → long polyglutamine protein → misfolding + toxic protein aggregates.

Leave a Reply

Your email address will not be published. Required fields are marked *